Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 pharmacology of TAP-144-SR (6M) in untreated prostate cancer
jRCT2080221327Phase 2
- Sponsor
- Takeda
- Start
- Dec 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of leuprolide in prostate cancer (PCa), sponsored by Takeda.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on jRCT2080221327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221327.